25 results on '"Ramassamy, Charles"'
Search Results
2. Periphery-confined particulate systems for the management of neurodegenerative diseases and toxicity: Avoiding the blood-brain-barrier challenge
3. Effect of polymer architecture on curcumin encapsulation and release from PEGylated polymer nanoparticles: Toward a drug delivery nano-platform to the CNS
4. Comparative application of pressure- and electrically-driven membrane processes for isolation of bioactive peptides from soy protein hydrolysate
5. Neurotherapeutic applications of nanoparticles in Alzheimer's disease
6. Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-β cascade
7. Receptor for advanced glycation end products and glyoxalase-1 in the total circulating extracellular vesicles from mild cognitive impairment and Alzheimer's disease patients.
8. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets
9. Overcoming the Brain Barriers: From Immune Cells to Nanoparticles.
10. Donepezil-loaded extracellular vesicles to mitigate both reactive oxygen species and inflammatory damage as a therapeutic approach for Alzheimer's disease.
11. Neuroprotective mechanisms of the standardized extract of Bacopa monniera in a paraquat/diquat-mediated acute toxicity.
12. Proteomic analysis of brain protein expression levels in NF-κβ p50 −/− homozygous knockout mice
13. Profile of pathogenic proteins in total circulating extracellular vesicles in mild cognitive impairment and during the progression of Alzheimer's disease.
14. Blood-based redox-signature and their association to the cognitive scores in MCI and Alzheimer's disease patients.
15. Effect of APOE ε4 allele and redox signature in circulating extracellular vesicles in cognitively impaired patients converted to Alzheimer's disease.
16. Effect of APOE ε4 Allele on Levels of Apolipoproteins E, J, and D, and Redox Signature In Circulating Extracellular Vesicles from Cognitively Impaired with No Dementia Participants Converted to Alzheimer's Disease.
17. Downregulation of Nrf2/HO-1 pathway and activation of JNK/c-Jun pathway are involved in homocysteic acid-induced cytotoxicity in HT-22 cells.
18. Acrolein induces Alzheimer's disease-like pathologies in vitro and in vivo
19. Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells
20. Screening of in vitro bioactivities of a soy protein hydrolysate separated by hollow fiber and spiral-wound ultrafiltration membranes
21. Protection by EGb 761 against β-amyloid-induced neurotoxicity: Involvement of NF-κB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation
22. Nanoparticle shell structural cues drive in vitro transport properties, tissue distribution and brain accessibility in zebrafish.
23. P 141 - Peripheral oxidative profile and specific advanced glycation end products can be a signature of cognitive decline in Alzheimer's disease.
24. O-21 - Management of apolipoprotein D and klotho levels, redox pattern and oxidative damages in plasma from MCI and Alzheimer′s Disease patients.
25. 294 - Protein Carbonyl, Total Antioxidant Capacity and Reduced Thiols in Plasma from Alzheimer's Patients Is Inversely Associated with Cognitive Performance.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.